MedPath

A nationwide cohort study on benign liver tumors and cysts in the Netherlands

Recruiting
Conditions
Solid lesionsFocal nodular hyperplasiaHaemangiomaHepatocellular adenomaHepatic haemangioendotheliomaCystic lesionsSimple hepatic cystsMucinous cystic neoplasm of the liver and biliary system Intraductal papillary neoplasms of the liver and bile ducts
Registration Number
NL-OMON20812
Lead Sponsor
/a
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
450
Inclusion Criteria

Adult patients (>18 years old) presenting with a common and/or clinically relevant BLTC at participating centers are eligible for inclusion. Clinically relevant BLTCs are defined as all BLTCs potentially eligible for either surgical intervention or follow-up.

Exclusion Criteria

- Age < 18 years
- Unable to fill in questionnaires
- Unable to comprehend the Dutch language sufficiently
- Severe quality of life impairment by alternate pathology

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in PROs including severity of symptoms from the start compared to the end of the follow-up period.<br>PROs: anxiety, fatigue, ability to participate and pain interference using computerized adaptive testing through the Dutch-Flemish Patient-Reported Outcomes Measurement Information System (PROMIS), numerical rating scales for pain (current and most, least, and average pain over a week) and two general health and quality of life questions
Secondary Outcome Measures
NameTimeMethod
Surgical outcomes & tumor specific complications
© Copyright 2025. All Rights Reserved by MedPath